Share Article
Urenco helps Thames Hospice with new site opening
13 October 2020 Urenco UK NewsMembers of Urenco’s Head Office team were delighted to support Thames Hospice get ready for the official opening of their new site.
The facility in Maidenhead opens today, providing crucial care for patients and their families in our community.
The Urenco team’s role was to help prepare and move garden furniture that will allow the patients to enjoy views of the beautiful gardens and Bray Lake.
Sally Goodenough, who coordinates Urenco’s volunteering efforts, said: “Giving back to our communities is an important part of Urenco’s sustainability programme. Each year every employee can provide eight hours of support to a local organisation within work hours, with several choosing to supplement this in their own time.
“Our Head Office employees selected Thames Hospice as a charity they wished to assist, with both donations and volunteering. We look forward to helping with future initiatives.”
Share Article
About Urenco
Urenco is an international supplier of uranium enrichment services, fuel cycle products and related solutions with sustainability at the core of our business. Operating in a pivotal area of the nuclear fuel supply chain for over 50 years, Urenco understands the importance of energy security and facilitates the reliable delivery of low carbon electricity generation for consumers around the world.
With its head office in London, UK, Urenco’s global presence ensures diversity and security of supply for customers through enrichment facilities in Germany, the Netherlands, the UK and the USA. Through our technology and the expertise of our people, the Urenco Group provides safe, cost effective and reliable services, operating within a framework of high environmental, social and governance standards, complementing international safeguards.
Urenco is making a positive contribution to global climate change goals through our core business and we are committed to achieving net zero carbon emissions by 2040.
We are committed to continued investment in the responsible management of nuclear materials; innovation activities with clear sustainability benefits, such as nuclear medicine, industrial efficiency and research; and nurturing the next generation of scientists and engineers.
Media enquiries